Here are five quick points:
1. The flu kills between 250,000 and 500,000 people globally every year, according to the World Health Organization.
2. The researchers found an antibody class that tells the immune system to identify a piece of the flu virus that doesn’t change from season to season.
3. The researchers now know where the antibodies bind, so they are working on modifying vaccines to generate high amounts of those antibodies.
4. The goal is to create a vaccine that is administered one time, protecting people from every flu strain.
5. The researchers are hopeful they can develop a universal flu vaccine within the next five years.
More articles on quality & infection control:
Was the ICD-10 transition really that terrible? 5 observations
CDC: Couples with Zika risk should wait longer prior to pregnancy
4 things to know about the US infection prevention products & services market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
